FDA Approved: PROPOFOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Propofol submitted by Hikma Pharmaceuticals USA Inc., authorizing the marketing of a generic propofol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia
• Intensive Care Unit Sedation

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

SUPPL AP for PROPOFOL (PROPOFOL)